Antiretroviral therapy coverage for PMTCT in Pakistan
Pakistan: Antiretroviral therapy coverage for PMTCT was 14.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Pakistan, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
Pakistan recorded 14.0% for antiretroviral therapy coverage for pmtct in 2024.
The figure is up 55.6% on the previous year and up 366.7% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Pakistan peaked at 15.0% in 2021 and was at its lowest, 0.0%, in 2000.
That places Pakistan 81st out of 84 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Pakistan, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 2.0% | — |
| 2007 | 1.0% | -50.0% |
| 2008 | 2.0% | +100.0% |
| 2009 | 2.0% | +0.0% |
| 2010 | 3.0% | +50.0% |
| 2011 | 6.0% | +100.0% |
| 2012 | 3.0% | -50.0% |
| 2013 | 8.0% | +166.7% |
| 2014 | 3.0% | -62.5% |
| 2015 | 10.0% | +233.3% |
| 2016 | 6.0% | -40.0% |
| 2017 | 7.0% | +16.7% |
| 2018 | 12.0% | +71.4% |
| 2019 | 14.0% | +16.7% |
| 2020 | 4.0% | -71.4% |
| 2021 | 15.0% | +275.0% |
| 2022 | 10.0% | -33.3% |
| 2023 | 9.0% | -10.0% |
| 2024 | 14.0% | +55.6% |
Pakistan compared with similar countries
- Pakistan's 14.0% is below the median for lower middle income countries, which is 83.5%, 17% of the median. (32 countries reporting)
- Pakistan's 14.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 32.0%, 44% of the median. (9 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.7% | 0.0% | 2.0% | 10 |
| 2010s | 7.2% | 3.0% | 14.0% | 10 |
| 2020s | 10.4% | 4.0% | 15.0% | 5 |
Countries ranked near Pakistan
- 78 Papua New Guinea 28.0% compare
- 79 Egypt 27.0% compare
- 80 Philippines 16.0% compare
- 81 Afghanistan 14.0% compare
- 83 Yemen 11.0% compare
- 84 Sudan 5.0% compare
More health data for Pakistan
- Un projection of annual infant deaths, annual growth rate -2.14 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8219 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 944.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 55,286 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 335 (2025)
- Population ages 00-04, female, annual growth rate 0.5028 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0616 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4109 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Pakistan?
- Antiretroviral therapy coverage for pmtct in Pakistan was 14.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Pakistan?
- The highest recorded value was 15.0% in 2021.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Pakistan?
- The lowest recorded value was 0.0% in 2000.
- How does Pakistan rank for antiretroviral therapy coverage for pmtct?
- Pakistan ranks 81st out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Pakistan?
- Over the last ten years it is up 366.7%. The long-run trend across the full record is volatile.
- Where does this Pakistan data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).